Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 36.99
+0.23 (0.63%)
Mar 30, 2026, 3:00 PM CST
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 5.85 billion as of March 27, 2026. Its market cap has increased by 58.44% in one year.
Market Cap
5.85B
Enterprise Value
5.49B
Revenue
871.31M
Ranking
n/a
PE Ratio
101.09
Stock Price
36.99
Market Cap Chart
Since August 27, 2018, SHA:603590's market cap has increased from 5.61B to 5.85B, an increase of 4.23%. That is a compound annual growth rate of 0.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 5.85B | -7.52% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Weiguang Biological Products | 6.24B |
| Xiangxue Pharmaceutical | 6.23B |
| GemPharmatech | 6.00B |
| Lifecome Biochemistry | 5.92B |
| R&G PharmaStudies | 5.91B |
| Shanghai OPM Biosciences | 5.80B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.77B |
| Novogene | 5.59B |